Sartorius Yönetim

Yönetim kriter kontrolleri 4/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Joachim Kreuzburg

İcra Kurulu Başkanı

€1.8m

Toplam tazminat

CEO maaş yüzdesi	59.5%
CEO görev süresi	22yrs
CEO sahipliği	0.04%
Yönetim ortalama görev süresi	4.3yrs
Yönetim Kurulu ortalama görev süresi	7.6yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Joachim Kreuzburg'un ücretlendirmesi Sartorius'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	€77m
Jun 30 2024	n/a	n/a	€78m
Mar 31 2024	n/a	n/a	€149m
Dec 31 2023	€2m	€1m	€205m
Sep 30 2023	n/a	n/a	€358m
Jun 30 2023	n/a	n/a	€495m
Mar 31 2023	n/a	n/a	€566m
Dec 31 2022	€2m	€1m	€678m
Sep 30 2022	n/a	n/a	€534m
Jun 30 2022	n/a	n/a	€489m
Mar 31 2022	n/a	n/a	€434m
Dec 31 2021	€3m	€1m	€319m
Sep 30 2021	n/a	n/a	€372m
Jun 30 2021	n/a	n/a	€332m
Mar 31 2021	n/a	n/a	€254m
Dec 31 2020	€2m	€903k	€210m
Sep 30 2020	n/a	n/a	€181m
Jun 30 2020	n/a	n/a	€154m
Mar 31 2020	n/a	n/a	€165m
Dec 31 2019	€2m	€888k	€157m
Sep 30 2019	n/a	n/a	€171m
Jun 30 2019	n/a	n/a	€166m
Mar 31 2019	n/a	n/a	€153m
Dec 31 2018	€2m	€863k	€141m
Sep 30 2018	n/a	n/a	€138m
Jun 30 2018	n/a	n/a	€126m
Mar 31 2018	n/a	n/a	€115m
Dec 31 2017	€2m	€832k	€115m

Tazminat ve Piyasa: Joachim 'nin toplam tazminatı ($USD 1.87M ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 4.78M ).

Tazminat ve Kazançlar: Joachim 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Joachim Kreuzburg (59 yo)

22yrs

Görev süresi

€1,783,000

Tazminat

Dr. rer. pol. Joachim Kreuzburg serves as the Chairman and Chief Executive Officer at Sartorius Stedim Biotech GmbH.Dr. rer. pol. Kreuzburg has been the Chairman of Executive Board at Sartorius Aktiengese...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Joachim Kreuzburg	Chairman of Executive Board & CEO	22yrs	€1.78m	0.040% € 5.3m
Rene Faber	Head of Bioprocess Solutions Division & Member of Executive Board	5.8yrs	€906.00k	Veri yok
Alexandra Gatzemeyer	Head of the Lab Products & Services Division and Member of Executive Board	1.5yrs	€537.00k	Veri yok
Petra Kirchhoff	Head of Corporate Communications & Investor Relations and Member of Supervisory Board	7.9yrs	€82.00k	Veri yok
Florian Funck	CFO & Member of Executive Board	less than a year	Veri yok	Veri yok
Patricia Spannagel	Head of Quality Assurance - Mechatronics Division Goettingen	no data	Veri yok	Veri yok
Ralf Mohrschladt	Physicist & Head of Supply Chain Management - Germany	no data	Veri yok	Veri yok
Petra Muller	Head of Investor Relations	2.8yrs	Veri yok	Veri yok
Maurice Phelan	President of Sartorius North America	1.8yrs	Veri yok	Veri yok
Theo Thijssen	President of Environmental Technology Division	23.1yrs	Veri yok	Veri yok

4.3yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim: SRT3 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Petra Kirchhoff	Head of Corporate Communications & Investor Relations and Member of Supervisory Board	14.1yrs	€82.00k	Veri yok
Klaus Trutzschler	Independent Member of Supervisory Board	13yrs	€186.00k	Veri yok
Annette Becker	Employee Representative Member of Supervisory Board	22.2yrs	€120.00k	Veri yok
Frank Riemensperger	Member of Supervisory Board	2.7yrs	€81.00k	Veri yok
Lothar Kappich	Chairman of Supervisory Board	17.6yrs	€365.00k	Veri yok
Daniela Favoccia	Independent Member of Supervisory Board	7.6yrs	€82.00k	Veri yok
Manfred Zaffke	Employee Representative Vice Chairman of Supervisory Board	10.7yrs	€201.00k	Veri yok
Ilke Panzer	Independent Member of Supervisory Board	7.6yrs	€82.00k	Veri yok
David Ebsworth	Independent Member of Supervisory Board	4.8yrs	€82.00k	Veri yok
Dietmar Muller	Employee Representative Member of Supervisory Board	4.5yrs	€118.00k	Veri yok
Hermann Ritzau	Member of Supervisory Board	3.7yrs	€82.00k	Veri yok
Sabrina Wirth	Member of the Supervisory Board	2.7yrs	€81.00k	Veri yok

7.6yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SRT3 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.6 yıldır).

Sartorius Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Sartorius Aktiengesellschaft, Annual General Meeting, Mar 28, 2024

Sartorius Announces Executive Board Changes

Sartorius Announces Management Changes for Sartorius North America

Sartorius Aktiengesellschaft, Annual General Meeting, Mar 29, 2023

Recent updates

Sartorius Aktiengesellschaft to Report Fiscal Year 2024 Results on Jan 28, 2025

Now 21% undervalued

Consensus EPS estimates fall by 14%

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Labforward GmbH acquired LabTwin GmbH from Sartorius Aktiengesellschaft (XTRA:SRT3).

Now 21% undervalued after recent price drop

Consensus EPS estimates fall by 37%

Price target decreased by 7.0% to €287

Second quarter 2024 earnings: Revenues exceed analyst expectations

Now 23% undervalued after recent price drop

Consensus EPS estimates fall by 12%

First quarter 2024 earnings: Revenues miss analyst expectations

Upcoming dividend of €0.74 per share

New minor risk - Profit margin trend

Full year 2023 earnings: EPS misses analyst expectations

Dividend of €0.74 announced

Sartorius Aktiengesellschaft to Report Fiscal Year 2023 Final Results on Feb 16, 2024

Sartorius Aktiengesellschaft to Report Q3, 2024 Results on Oct 17, 2024

Sartorius Aktiengesellschaft to Report Fiscal Year 2023 Results on Jan 26, 2024

Investor sentiment improves as stock rises 18%

Consensus EPS estimates fall by 29%

Price target decreased by 8.9% to €330

Sartorius Aktiengesellschaft, Annual General Meeting, Mar 28, 2024

Third quarter 2023 earnings: Revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 21%

Sartorius Ag Lowers Earnings Forecast for the Fiscal Year 2023

Sartorius Announces Executive Board Changes

Second quarter 2023 earnings: Revenues miss analyst expectations

Investor sentiment improves as stock rises 17%

Price target decreased by 11% to €356

New minor risk - Share price stability

Price target decreased by 9.4% to €386

Consensus EPS estimates fall by 13%

First quarter 2023 earnings released

Upcoming dividend of €1.44 per share at 0.4% yield

Full year 2022 earnings released

Sartorius Aktiengesellschaft Provides Revenue Guidance for the Full Year 2023

Sartorius Announces Management Changes for Sartorius North America

Investor sentiment improved over the past week

Price target decreased to €436

Sartorius Aktiengesellschaft, Annual General Meeting, Mar 29, 2023

Sartorius Aktiengesellschaft to Report First Half, 2023 Results on Jul 21, 2023

Investor sentiment improved over the past week

Sartorius Aktiengesellschaft Confirms Consolidated Financial Guidance for the Year 2022

Sartorius AG Proposes Ordinary Dividend for the Year 2021

Sartorius Aktiengesellschaft Provides Consolidated Sales Revenue Guidance for the Fiscal Year 2022 and Reaffirms Consolidated Sales Revenue for the Year 2025

Sartorius Aktiengesellschaft (XTRA:SRT) entered into an agreement to acquire a 62.5% stake in ALS Automated Lab Solutions GmbH.

Sartorius Provides Earnings Guidance for the First Half Ended June 30, 2021

Sartorius Raises Group Earnings Guidance for the Full Year 2021

Sartorius Plans to Acquire Remaining Shares of Cellgenix

Sartorius AG Raises Revenue Guidance for the Year 2021

Sartorius Revises Earnings Guidance for the Year 2021

Sartorius Aktiengesellschaft to Report Fiscal Year 2020 Final Results on Feb 18, 2021

Sartorius Aktiengesellschaft to Report Q1, 2021 Results on Apr 21, 2021

Sartorius Aktiengesellschaft (XTRA:SRT) agreed to acquire just over 50% stake in Biological Industries Israel Beit Haemek Ltd. from Kibbutz Beit Haemek and Fortissimo Capital, L.P. managed by Fortissimo Capital for approximately €45 million.

Sartorius Aktiengesellschaft to Report Q3, 2020 Results on Oct 20, 2020

Sartorius Aktiengesellschaft (XTRA:SRT) and Sartorius Stedim Biotech S.A. (ENXTPA:DIM) completed the acquisition of certain businesses from Danaher Corporation (NYSE:DHR).

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş